PharmaBoardroom

Chiesi Moves into Rare Diseases & the US Market

Italian mid-cap firm Chiesi is continuing its expansion in the USA market with the launch of a Boston-based subsidiary focusing on rare and ultra-rare…

US FDA New Drug Approvals 2019 Snapshot

Annual numbers of new molecular entities (NMEs) and biologics license applications (BLAs) approved by the FDA's Center for Drug Evaluation and…

Barbara Lopez Kunz – CEO, Drug Information Association…

Barbara Lopez Kunz, CEO of the Drug Information Association (DIA) in the USA, outlines the association’s four key areas of focus – regulatory…

Indian Pharma Supply Chain Hit by Coronavirus Outbreak

The ongoing coronavirus outbreak and the subsequent shutdown of factories in China is having severe repercussions for Indian pharma manufacturers and…

New Hungary Pharma Report 2020 Out Now

In line with its status as one of Europe’s most dynamic economies, Hungary is aiming to boost both its life sciences industry and the level of…

Top 10 Pharma Companies in Morocco Ranking

The top 10 pharma companies in Morocco ranked by sales value for Q4 2018. French giant Sanofi takes top spot, followed by local players Cooper and…

USMCA Sets a New Standard for International Trade

Jonathan Kimball of the Association for Accessible Medicines (AAM) in the USA outlines why the signing of the US-Mexico-Canada Agreement (USMCA) in…

Roman Badik – CEO, Enantis, Czech Republic

Roman Badik, CEO of Enantis, the first biotechnology spin-off from Masaryk University in the Czech Republic, shares his vision of turning the…

Cristóbal Thompson – Executive Director, AMIIF, Mexico

In the historic year of their 70th anniversary, Cristóbal Thompson, executive director of the Asociación Mexicana de Industrias de Investigación…

Augustin Bernát – General Manager, ResMed Czech Republic

Augustin Bernát, general manager for the Czech affiliate of ResMed, a company whose cloud-connected medical devices transform care for people with…

Rafael Gual Cosío – Director General, CANIFARMA, Mexico

Rafael Gual Cosío, director general of the Cámara Nacional de la Industria Farmacéutica (CANIFARMA), the umbrella industry association for the…

Eric Deschepper – Managing Director, Teva Pharma Belgium

Teva Pharma Belgium's Eric Deschepper outlines how the global group's restructuring has impacted its Belgian operations, its realignment from a pure…

Tagged with A